Antimicrobial Resistance Diagnostics Market

Antimicrobial Resistance Diagnostics Market (Technology: Microbiology Culture, PCR, NGS, Mass Spectrometry, Rapid & Point of Care and Others; Pathogen: Drug Resistant Streptococcus Pneumoniae (DRSP), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRNTS) and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Antimicrobial Resistance Diagnostics Market Outlook 2035

The global antimicrobial resistance diagnostics market was valued at US$ 4.5 Bn in 2024
The global antimicrobial resistance diagnostics industry is projected to grow at a CAGR of 6.5% from 2025 to 2035 and reach US$ 8.9 Bn by the end of 2035

Analysts’ Viewpoint regarding Antimicrobial Resistance Diagnostics Market

The antimicrobial resistance (AMR) diagnostics market’s growth is fueled by the prevalence of antibiotic-resistant infection and demand for effective diagnostic tests. AMR poses a worldwide threat to global health and causes increased hospitalization, extra healthcare costs, and increased mortality. With healthcare systems facing the threat, the market for new diagnostics has expanded to a greater extent.

Market growth is also driven by molecular diagnostics technology for the early identification of drug-resistant bacteria. Most effective technologies are PCR (Polymerase Chain Reaction), next-generation sequencing, and mass spectrometry, which are of high specificity and sensitivity. In addition, growing awareness on the effect of AMR among patients as well as doctors is driving R&D spending.

Global Antimicrobial Resistance Diagnostics Market Regional Analysis Revanue Growth 2025 To 2035

North America leads the market due to robust healthcare infrastructure, coupled with government efforts in counteracting AMR. The growth rate will, however, be the highest in the Asia Pacific as growth is fueled by increasing expenditure in healthcare as well as the expanding infectious disease burden.

Antimicrobial Resistance Diagnostics Market Introduction

Antimicrobial resistance (AMR) testing is an excellent weapon in the fight against the global health emergency of antibiotic-resistant illness. As bacteria become increasingly resistant, established treatments fail, the illness becomes longer-lasting and, at times, life-threatening as well. AMR diagnostics are a variety of methods that seek to quickly and accurately identify resistant bacteria so that proper treatment by medical staff can be undertaken.

The other significant diagnostic tools are molecular tools such as PCR and next-generation sequencing, which give faster results. This technology contributes significantly toward timely intervention as well as avoiding abuse of antibiotics.

As growing attention is being directed toward the impact of AMR, money has started coming in for further research and development work within diagnostics. With all the global healthcare systems setting energies toward combating AMR, there is a growing demand for effective diagnostic methods as well. As such, science has become an essential part of the search for improved patient results and strong public health interventions.

Attribute	Detail
Antimicrobial Resistance Diagnostics Market Drivers	Rising Incidence of AMR Infections Advancements in Diagnostic Technologies

Rising Incidence of AMR Infections Driving Antimicrobial Resistance Diagnostics Market Size

The growing incidences of antimicrobial resistance (AMR) infections primarily drives the antimicrobial resistance diagnostics market. With bacteria increasingly resisting traditional antibiotics, the infections caused due to resistant strains are on the rise. Urinary tract infections, pneumonia, and bloodstream infection are turning out to be more linked to the resistant pathogens, thereby making it difficult to treat them.

Effective diagnostics of AMR does facilitate directed treatment, thereby not only improving patient outcomes but also averting the abuse of antibiotics.

North America and Europe dominate the market; as healthcare infrastructure is conducive to sophisticated diagnostic solutions. The Asia-Pacific region is, however, gaining the spotlight with increased investment in the healthcare industry and increasing burdens of infectious diseases. Since the globe is still to find a solution to the AMR, there will also be an increasing requirement for new diagnostic solutions, thereby continuing to drive the market expansion.

Advancements in Diagnostic Technologies Bolstering Antimicrobial Resistance Diagnostics Market

Diagnostics technology advancements are significantly pushing the antimicrobial resistance (AMR) diagnostics market growth. Novel techniques like polymerase chain reaction (PCR), next-generation sequencing (NGS), and mass spectrometry have transformed detection and characterization of antibiotic-resistant organisms among clinicians.

In addition, advancements in diagnostic technology regarding point-of-care enable real-time diagnostics in rural areas, thereby improving patient care and response times. Additionally, the incorporation of AI and ML into diagnosis platforms enhances the diagnostic efficacy of AMR detection, thereby resulting in more personalized treatment regimens.

PCR Technology leading Antimicrobial Resistance Diagnostics Market

Polymerase Chain Reaction (PCR) technology leads the AMR diagnostics market as it is unrivaled for sensitivity, specificity, and speed in identifying resistant pathogens. PCR is capable of amplifying the existing DNA target sequence to detect bacterial strains and resistance genes with high specificity. Quick turnaround is crucial in the clinical setting, where diagnosis can significantly impact patient treatment and outcome.

Global Antimicrobial Resistance Diagnostics Market By Technology

The second advantage of PCR is that it is versatile. As such, it can be designed to detect a huge range of types of pathogens and resistance markers in blood, urine, and swabs. In addition, multiplex PCR and real-time PCR technology enables one to detect more than a single target at a time, and it is more economical to use in diagnostics.

While health systems still strive toward rapid and accurate diagnosis in an attempt to combat AMR, the capacity of PCR technology to deliver speedy results with fewer false positives and false negatives positions it strongly in the market.

Regional Outlook of Antimicrobial Resistance Diagnostics Market

Attribute	Detail
Leading Region	North America

North America is leading the antimicrobial resistance (AMR) diagnostics market based on a mix of strong healthcare infrastructure, heavy research investment, and aggressive government initiatives. The region has well-equipped laboratory facilities with modern diagnostic machines like PCR and next-generation sequencing that enhance the speed and efficiency of detection of AMR.

Global Antimicrobial Resistance Diagnostics Market Regional Analysis 2025 To 2035 (1)

The large base of healthcare-associated infections in North America is also fueling demand for effective diagnostics against resistant infections. As a result, the diagnostics market for AMR is expanding at a considerable rate in the region subsequent to the focus on enhancing patient outcomes and reinforcing public health policy.

Analysis of Key Players in Antimicrobial Resistance Diagnostics Market

Key players in the global market are investing in innovation, technological advancements, and forming alliances. Their objective is to improve the precision of testing, diversify their products, and gain a stronger market presence in order to be ahead of the curve in the evolving healthcare market.

BioMerieux, F. Hoffmann-La Roche AG, Abbott, BD, Accelerate Diagnostics, Inc., Molsid, Vela Diagnostics, Bruker, Bio-Rad and others are some of the leading players.

Each of these players has been profiled in the antimicrobial resistance diagnostics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Antimicrobial Resistance Diagnostics Market

In October 2024, FIND and the Kingdom of Saudi Arabia announced the convening of a high-level side event focused on closing gaps in diagnostics to prevent AMR. This initiative aims to tackle AMR and is expected to expand the organization's reach into untapped economies.
In July 2024, Gujarat state announced that they had launched a State Action Plan for the Containment of antimicrobials to control AMR within the state.

Antimicrobial Resistance Diagnostics Market Snapshot

Attribute	Detail
Size in 2024	US$ 4.5 Bn
Forecast Value in 2035	US$ 8.9 Bn
CAGR	6.5%
Forecast Period	2025-2035
Historical Data Available for	2020-2023
Quantitative Units	US$ Bn
Antimicrobial Resistance Diagnostics Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Technology Microbiology Culture PCR NGS Mass Spectrometry Rapid & Point of Care Others (Immunoassay, etc.) Pathogen Drug Resistant Streptococcus Pneumoniae (DRSP) Clostridium Difficile (CD) Methicillin Resistant Staphylococcus Aureus (MRSA) Drug Resistant Neisseria Gonorrhoeae (DRNG) Drug Resistant Salmonella (DRNTS) Others (Drug Resistant Campylobacter (DRC)) End-user Hospitals Diagnostic Laboratories Pharmaceutical & Biotechnology Companies Others (Research Institutes, etc.)
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain Switzerland The Netherlands China India Japan South Korea Australia and New Zealand Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	BioMerieux F. Hoffmann-La Roche AG Abbott BD Accelerate Diagnostics, Inc. Molsid Vela Diagnostics Bruker Bio-Rad Other Prominent Players
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global antimicrobial resistance diagnostics market in 2024?

It was valued at US$ 4.5 Bn in 2024

What is the projected size of the antimicrobial resistance diagnostics market by 2035?

It is projected to cross US$ 8.9 Bn by the end of 2035

What are the factors driving the antimicrobial resistance diagnostics market?

Rising incidence of AMR infections and advancements in diagnostic technologies

What is the antimicrobial resistance diagnostics industry expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 6.5% from 2025 to 2035

Which region is expected to dominate the antimicrobial resistance diagnostics market during the forecast period?

North America is expected to account for the largest share from 2025 to 2035

Who are the prominent antimicrobial resistance diagnostics providers?

BioMerieux, F. Hoffmann-La Roche AG, Abbott, BD, Accelerate Diagnostics, Inc., Molsid, Vela Diagnostics, Bruker, Bio-Rad and Others

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Antimicrobial Resistance Diagnostics Market
Market Overview
- Introduction
  - Segment Definition
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Antimicrobial Resistance Diagnostics Market Analysis and Forecast, 2020–2035
  - Market Revenue Projections (US$ Bn)
Key Insights
- Technological Advancement
- PORTER’s Five Forces Analysis
- PESTLE Analysis
- Supply Chain Analysis
- Regulatory Landscape across Key Regions / Countries
- Go-to-Market Strategy for New Market Entrants
Global Antimicrobial Resistance Diagnostics Market Analysis and Forecast, by Technology
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Technology, 2020–2035
  - Microbiology Culture
  - PCR
  - NGS
  - Mass Spectrometry
  - Rapid & Point of Care
  - Others
- Market Attractiveness Analysis, by Technology
Global Antimicrobial Resistance Diagnostics Market Analysis and Forecast, by Pathogen
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Pathogen, 2020–2035
  - Drug Resistant Streptococcus Pneumoniae (DRSP)
  - Clostridium Difficile (CD)
  - Methicillin Resistant Staphylococcus Aureus (MRSA)
  - Drug Resistant Neisseria Gonorrhoeae (DRNG)
  - Drug Resistant Salmonella (DRNTS)
  - Others
- Market Attractiveness Analysis, by Pathogen
Global Antimicrobial Resistance Diagnostics Market Analysis and Forecast, by End-user
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by End-user, 2020–2035
  - Hospitals
  - Diagnostic Laboratories
  - Pharmaceutical & Biotechnology Companies
  - Others
- Market Attractiveness Analysis, by End-user
Global Antimicrobial Resistance Diagnostics Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2020–2035
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness Analysis, by Region
North America Antimicrobial Resistance Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Technology, 2020–2035
  - Microbiology Culture
  - PCR
  - NGS
  - Mass Spectrometry
  - Rapid & Point of Care
  - Others
- Market Value Forecast, by Pathogen, 2020–2035
  - Drug Resistant Streptococcus Pneumoniae (DRSP)
  - Clostridium Difficile (CD)
  - Methicillin Resistant Staphylococcus Aureus (MRSA)
  - Drug Resistant Neisseria Gonorrhoeae (DRNG)
  - Drug Resistant Salmonella (DRNTS)
  - Others
- Market Value Forecast, by End-user, 2020–2035
  - Hospitals
  - Diagnostic Laboratories
  - Pharmaceutical & Biotechnology Companies
  - Others
- Market Value Forecast, by Country, 2020–2035
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Technology
  - By Pathogen
  - By End-user
  - By Country
Europe Antimicrobial Resistance Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Technology, 2020–2035
  - Microbiology Culture
  - PCR
  - NGS
  - Mass Spectrometry
  - Rapid & Point of Care
  - Others
- Market Value Forecast, by Pathogen, 2020–2035
  - Drug Resistant Streptococcus Pneumoniae (DRSP)
  - Clostridium Difficile (CD)
  - Methicillin Resistant Staphylococcus Aureus (MRSA)
  - Drug Resistant Neisseria Gonorrhoeae (DRNG)
  - Drug Resistant Salmonella (DRNTS)
  - Others
- Market Value Forecast, by End-user, 2020–2035
  - Hospitals
  - Diagnostic Laboratories
  - Pharmaceutical & Biotechnology Companies
  - Others
- Market Value Forecast, by Country/Sub-region, 2020–2035
  - Germany
  - UK
  - France
  - Italy
  - Spain
  - Switzerland
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Technology
  - By Pathogen
  - By End-user
  - By Country/Sub-region
Asia Pacific Antimicrobial Resistance Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Technology, 2020–2035
  - Microbiology Culture
  - PCR
  - NGS
  - Mass Spectrometry
  - Rapid & Point of Care
  - Others
- Market Value Forecast, by Pathogen, 2020–2035
  - Drug Resistant Streptococcus Pneumoniae (DRSP)
  - Clostridium Difficile (CD)
  - Methicillin Resistant Staphylococcus Aureus (MRSA)
  - Drug Resistant Neisseria Gonorrhoeae (DRNG)
  - Drug Resistant Salmonella (DRNTS)
  - Others
- Market Value Forecast, by End-user, 2020–2035
  - Hospitals
  - Diagnostic Laboratories
  - Pharmaceutical & Biotechnology Companies
  - Others
- Market Value Forecast, by Country/Sub-region, 2020–2035
  - China
  - India
  - Japan
  - South Korea
  - Australia & New Zealand
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Technology
  - By Pathogen
  - By End-user
  - By Country/Sub-region
Latin America Antimicrobial Resistance Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Technology, 2020–2035
  - Microbiology Culture
  - PCR
  - NGS
  - Mass Spectrometry
  - Rapid & Point of Care
  - Others
- Market Value Forecast, by Pathogen, 2020–2035
  - Drug Resistant Streptococcus Pneumoniae (DRSP)
  - Clostridium Difficile (CD)
  - Methicillin Resistant Staphylococcus Aureus (MRSA)
  - Drug Resistant Neisseria Gonorrhoeae (DRNG)
  - Drug Resistant Salmonella (DRNTS)
  - Others
- Market Value Forecast, by End-user, 2020–2035
  - Hospitals
  - Diagnostic Laboratories
  - Pharmaceutical & Biotechnology Companies
  - Others
- Market Value Forecast, by Country/Sub-region, 2020–2035
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Technology
  - By Pathogen
  - By End-user
  - By Country/Sub-region
Middle East & Africa Antimicrobial Resistance Diagnostics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Technology, 2020–2035
  - Microbiology Culture
  - PCR
  - NGS
  - Mass Spectrometry
  - Rapid & Point of Care
  - Others
- Market Value Forecast, by Pathogen, 2020–2035
  - Drug Resistant Streptococcus Pneumoniae (DRSP)
  - Clostridium Difficile (CD)
  - Methicillin Resistant Staphylococcus Aureus (MRSA)
  - Drug Resistant Neisseria Gonorrhoeae (DRNG)
  - Drug Resistant Salmonella (DRNTS)
  - Others
- Market Value Forecast, by End-user, 2020–2035
  - Hospitals
  - Diagnostic Laboratories
  - Pharmaceutical & Biotechnology Companies
  - Others
- Market Value Forecast, by Country/Sub-region, 2020–2035
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Technology
  - By Pathogen
  - By End-user
  - By Country/Sub-region
Competition Landscape
- Market Player – Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2024)
- Company Profiles
  - BioMerieux
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - F. Hoffmann-La Roche AG
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Abbott
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - BD
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Accelerate Diagnostics, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Molsid
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Vela Diagnostics
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Bruker
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Bio-Rad
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments

List of Tables

Table 01: Global Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
Table 02: Global Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Pathogen, 2020 to 2035
Table 03: Global Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 04: Global Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 05: North America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 06: North America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
Table 07: North America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Pathogen, 2020 to 2035
Table 08: North America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 09: Europe Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 10: Europe Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
Table 11: Europe Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Pathogen, 2020 to 2035
Table 12: Europe Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 13: Asia Pacific Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 14: Asia Pacific Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
Table 15: Asia Pacific Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Pathogen, 2020 to 2035
Table 16: Asia Pacific Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 17: Latin America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 18: Latin America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
Table 19: Latin America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Pathogen, 2020 to 2035
Table 20: Latin America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 21: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 22: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
Table 23: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By Pathogen, 2020 to 2035
Table 24: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

Figure 01: Global Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Technology, 2024 and 2035
Figure 02: Global Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 03: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Microbiology Culture, 2020 to 2035
Figure 04: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by PCR, 2020 to 2035
Figure 05: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by NGS, 2020 to 2035
Figure 06: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Mass Spectrometry, 2020 to 2035
Figure 07: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Rapid & Point of Care, 2020 to 2035
Figure 08: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 09: Global Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Pathogen, 2024 and 2035
Figure 10: Global Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Pathogen, 2025 to 2035
Figure 11: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Drug Resistant Streptococcus Pneumoniae (DRSP), 2020 to 2035
Figure 12: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Clostridium Difficile (CD), 2020 to 2035
Figure 13: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Methicillin Resistant Staphylococcus Aureus (MRSA), 2020 to 2035
Figure 14: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Drug Resistant Neisseria Gonorrhoeae (DRNG), 2020 to 2035
Figure 15: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Drug Resistant Salmonella (DRNTS), 2020 to 2035
Figure 16: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 17: Global Antimicrobial Resistance Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 18: Global Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 19: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Hospitals, 2020 to 2035
Figure 20: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Diagnostic Laboratories, 2020 to 2035
Figure 21: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Pharmaceutical & Biotechnology Companies, 2020 to 2035
Figure 22: Global Antimicrobial Resistance Diagnostics Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 23: Global Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Region, 2024 and 2035
Figure 24: Global Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 25: North America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 26: North America Antimicrobial Resistance Diagnostics Market Value Share Analysis, by Country, 2024 and 2035
Figure 27: North America Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 28: North America Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Technology, 2024 and 2035
Figure 29: North America Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 30: North America Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Pathogen, 2024 and 2035
Figure 31: North America Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Pathogen, 2025 to 2035
Figure 32: North America Antimicrobial Resistance Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 33: North America Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 34: Europe Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 35: Europe Antimicrobial Resistance Diagnostics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 36: Europe Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 37: Europe Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Technology, 2024 and 2035
Figure 38: Europe Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 39: Europe Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Pathogen, 2024 and 2035
Figure 40: Europe Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Pathogen, 2025 to 2035
Figure 41: Europe Antimicrobial Resistance Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 42: Europe Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 43: Asia Pacific Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 44: Asia Pacific Antimicrobial Resistance Diagnostics Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 45: Asia Pacific Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 46: Asia Pacific Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Technology, 2024 and 2035
Figure 47: Asia Pacific Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 48: Asia Pacific Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Pathogen, 2024 and 2035
Figure 49: Asia Pacific Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Pathogen, 2025 to 2035
Figure 50: Asia Pacific Antimicrobial Resistance Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 51: Asia Pacific Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 52: Latin America Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 53: Latin America Antimicrobial Resistance Diagnostics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 54: Latin America Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 55: Latin America Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Technology, 2024 and 2035
Figure 56: Latin America Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 57: Latin America Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Pathogen, 2024 and 2035
Figure 58: Latin America Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Pathogen, 2025 to 2035
Figure 59: Latin America Antimicrobial Resistance Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 60: Latin America Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 61: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 62: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 63: Middle East & Africa Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 64: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Technology, 2024 and 2035
Figure 65: Middle East & Africa Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Technology, 2025 to 2035
Figure 66: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value Share Analysis, By Pathogen, 2024 and 2035
Figure 67: Middle East & Africa Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By Pathogen, 2025 to 2035
Figure 68: Middle East & Africa Antimicrobial Resistance Diagnostics Market Value Share Analysis, By End-user, 2024 and 2035
Figure 69: Middle East & Africa Antimicrobial Resistance Diagnostics Market Attractiveness Analysis, By End-user, 2025 to 2035